Literature DB >> 6298038

Central and peripheral nervous system complications.

M R Brown, P J Dyck, G E McClearn, A A Sima, H C Powell, D Porte.   

Abstract

Symptomatic neuropathy is a common manifestation of diabetes mellitus, and sensory, motor, or autonomic symptoms occur in approximately 10% of all diabetic patients. Animal models may be useful to study the metabolic and electrophysiologic abnormalities peculiar to diabetic neuropathy. Genetic animal models, including the Chinese hamster, ob/ob mouse, db/db mouse, BB-wistar rat, and SSDR rat or chemically induced or nutritional models of diabetes mellitus provide the potential to use animals to study human neuropathy; however, to date, few characteristics of human diabetic neuropathy have been clearly demonstrated in any of these animal models. Better characterization of the neuropathy of existing animal models with emphasis on evaluation over long periods of time is recommended. These studies should include a cross-disciplinary approach using biochemical, electrophysiologic and morphologic techniques. Specific future approaches to study diabetic neuropathy using chemical models is outlined in this chapter.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6298038     DOI: 10.2337/diab.31.1.s65

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  11 in total

1.  Hyperalgesia in spontaneous and experimental animal models of diabetic neuropathy.

Authors:  L Wuarin-Bierman; G R Zahnd; F Kaufmann; L Burcklen; J Adler
Journal:  Diabetologia       Date:  1987-08       Impact factor: 10.122

2.  The roles of streptozotocin neurotoxicity and neutral endopeptidase in murine experimental diabetic neuropathy.

Authors:  Eric Davidson; Lawrence Coppey; Bao Lu; Victor Arballo; Nigel A Calcutt; Craig Gerard; Mark Yorek
Journal:  Exp Diabetes Res       Date:  2010-02-03

3.  Distal symmetric polyneuropathy in the spontaneously diabetic BB-wistar rat. An ultrastructural and teased fiber study.

Authors:  A A Sima; A C Lorusso; P Thibert
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

4.  Leg symptoms in outpatient veterans.

Authors:  S K Oboler; A V Prochazka; T J Meyer
Journal:  West J Med       Date:  1991-09

5.  Reversible reduction in bone blood flow in streptozotocin-diabetic rats.

Authors:  P D Lucas
Journal:  Experientia       Date:  1987-08-15

6.  Experimental diabetic neuropathy: impairment of slow transport with changes in axon cross-sectional area.

Authors:  R Medori; L Autilio-Gambetti; S Monaco; P Gambetti
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

7.  Effect of diabetes on the enzymes of the cholinergic system of the rat brain.

Authors:  Z Z Wahba; K F Soliman
Journal:  Experientia       Date:  1988-09-15

8.  Microangiopathy in human diabetic neuropathy.

Authors:  H C Powell; J Rosoff; R R Myers
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

9.  Structural alterations of the intramuscular nerves and junctional region in extraocular muscles of C57BL/Ks (db/db) diabetic mice.

Authors:  B R Pachter
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

Review 10.  Criteria for creating and assessing mouse models of diabetic neuropathy.

Authors:  Kelli A Sullivan; Stephen I Lentz; John L Roberts; Eva L Feldman
Journal:  Curr Drug Targets       Date:  2008-01       Impact factor: 3.465

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.